Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1986-2-20
|
pubmed:abstractText |
Serum osteocalcin (OC) levels were measured in 19 asthmatic patients receiving long term glucocorticoid therapy and in age- and sex-matched asthmatic patients not receiving this treatment. In the glucocorticoid-treated patients, the mean OC level was approximately 50% less than that in the control group (P less than 0.001), and there was a direct correlation between serum OC and 1,25-dihydroxyvitamin D [1,25-(OH)2D; r = 0.71; P less than 0.001]. Multiple regression analysis in a total of 39 glucocorticoid-treated patients indicated that OC correlated directly to 1,25-(OH)2D and inversely to glucocorticoid dose. There was no correlation between OC and 1,25-(OH)2D in the control group and no significant difference in mean serum 1,25-(OH)2D between the steroid-treated asthmatic patients and the asthmatic control patients. The effect of a 4-day course of oral 1,25-(OH)2D on serum OC was studied in six patients with glucocorticoid excess and six normal subjects. There was a similar percent increase in OC levels in both groups, though the basal concentrations and absolute increases were substantially less in the steroid-treated group. It is likely that the depression of serum OC in glucocorticoid-treated patients results from the reduction in the rate of bone formation induced by these hormones.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/1,25-dihydroxyergocalciferol,
http://linkedlifedata.com/resource/pubmed/chemical/Alkaline Phosphatase,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Ergocalciferols,
http://linkedlifedata.com/resource/pubmed/chemical/Glucocorticoids,
http://linkedlifedata.com/resource/pubmed/chemical/Osteocalcin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0021-972X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
62
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
379-83
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3484482-Administration, Oral,
pubmed-meshheading:3484482-Adolescent,
pubmed-meshheading:3484482-Adult,
pubmed-meshheading:3484482-Aged,
pubmed-meshheading:3484482-Alkaline Phosphatase,
pubmed-meshheading:3484482-Asthma,
pubmed-meshheading:3484482-Calcium-Binding Proteins,
pubmed-meshheading:3484482-Ergocalciferols,
pubmed-meshheading:3484482-Female,
pubmed-meshheading:3484482-Glucocorticoids,
pubmed-meshheading:3484482-Humans,
pubmed-meshheading:3484482-Male,
pubmed-meshheading:3484482-Middle Aged,
pubmed-meshheading:3484482-Osteocalcin,
pubmed-meshheading:3484482-Radioimmunoassay
|
pubmed:year |
1986
|
pubmed:articleTitle |
Low serum osteocalcin levels in glucocorticoid-treated asthmatics.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|